D 099
Alternative Names: D-099Latest Information Update: 06 Mar 2024
At a glance
- Originator Integrated Nanotherapeutics; ME Therapeutics
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Preclinical Cancer